Trulieve Announces Grand Opening of Worcester Dispensary

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States, today announced the opening of its second Massachusetts dispensary, located in Worcester. The Worcester dispensary will open its doors to adult-use customers on Saturday, August 14 and is the company’s 97th store. This follows the June opening of Trulieve’s first Massachusetts location in Northampton.

Conveniently within a one-minute walk to Polar Park, Trulieve of Worcester will serve adult-use customers at 142-A Southbridge St. Worcester, Monday through Saturday from 9:00 a.m. to 10:00 p.m. and Sunday from 9:00 a.m. to 8:00 p.m.


To celebrate the grand opening, Trulieve invites the Worcester community to a block party on Saturday August, 14, 2021 from 11:00 am to 5:00 pm EST. The company has secured a permit to close the street and the festivities will include live music, partner brand tables, and several food trucks. Additionally, Trulieve celebrates the grand opening of another neighborhood dispensary, Major Bloom, an economic empowerment applicant that opens its doors this weekend at 76 Millbury St, Worcester, MA and will be hosting a grand opening celebration starting at 3:00 pm on Saturday.

Trulieve will offer a wide selection of cannabis products, including all of the company’s newest brands: Muse, Momenta, Sweet Talk, and Cultivar Collection along with a variety of Trulieve-branded products and partner brands.

“Building on the recent opening of our Northampton dispensary, we are excited to open in Worcester and bring our premium cannabis products to central Massachusetts,” said Kim Rivers, CEO of Trulieve. “Massachusetts adult-use cannabis customers are some of the first in the country to experience our new brand portfolio which provides a full assortment of the highest-quality cannabis products on the market today. From first-time consumers to those seeking to begin their own home grow with premium clones from Trulieve, we look forward to serving the Worcester community as we continue to expand in Massachusetts.”

About Trulieve

Trulieve is primarily a vertically integrated “seed-to-sale” company in the U.S. and is the first and largest fully licensed medical cannabis company in the State of Florida. Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve-branded dispensaries throughout the State of Florida, as well as directly to patients via home delivery. Trulieve also holds licenses to operate in California, Massachusetts, Pennsylvania, Connecticut and West Virginia. Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF.

To learn more about Trulieve, visit

The Canadian Securities Exchange has not reviewed, approved or disapproved the ‎content of this news release.‎

Forward-Looking Statements
This news release includes forward-looking information and statements, which may include, but are not limited to, information and statements regarding or inferring the future business, operations, financial performance, prospects, and other plans, intentions, expectations, estimates, and beliefs of the Company and statements with regard to the Report and the Company’s response thereto. Words such as “expects”, “continue”, “will”, “anticipates” and “intends” or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on the Company’s current projections and expectations about future events and financial trends that management believes might affect its financial condition, results of operations, business strategy and financial needs, and on certain assumptions and analysis made by the Company in light of the experience and perception of historical trends, current conditions and expected future developments and other factors management believes are appropriate. Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements herein, including, without limitation, the risks discussed under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2020 and in subsequent periodic and current reports filed with the United States Securities and Exchange Commission and in the Company’s filings on SEDAR at Although the Company believes that any forward-looking information and statements herein are reasonable, in light of the use of assumptions and the significant risks and uncertainties inherent in such information and statements, there can be no assurance that any such forward-looking information and statements will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking information and statements. Any forward-looking information and statements herein are made as of the date hereof, and except as required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking information and statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward looking information and statements herein, whether as a result of new information, future events or results, or otherwise, except as required by applicable laws.

View original content:

SOURCE Trulieve Cannabis Corp.

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 |
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Cara Therapeutics, Inc. (CARA) Announces Difelikefalin (KORSUVA™) Injection Achieves Positive Topline Results in Phase 3 Clinical Study

Cara Therapeutics Announces Difelikefalin (KORSUVA™) Injection Achieves Positive Topline Results in Phase…

Ascend Wellness Holdings, Inc. (AAWH) Announces Participation in Upcoming Conferences in May

AWH Announces Participation in Upcoming Conferences in May Ascend Wellness Holdings, Inc.…

$ATTBF Initiates Product Development

BioCell Labs Initiates Product Development VANCOUVER, BRITISH COLUMBIA–(Marketwired – Feb 10, 2015)…

The Alkaline Water Company Inc. (WTER) Launches A88CBD™ in CBD Emporium

The Alkaline Water Company Launches A88CBD™ in CBD Emporium   The Alkaline…